These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25498501)

  • 1. The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244.
    Wang T; Wei J; Wang N; Ma JL; Hui PP
    Biochem Biophys Res Commun; 2015 Jan; 456(3):821-6. PubMed ID: 25498501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production.
    Gong L; Yang B; Xu M; Cheng B; Tang X; Zheng P; Jing Y; Wu GJ
    Cancer Chemother Pharmacol; 2014 Jan; 73(1):69-77. PubMed ID: 24190701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis.
    Huang WC; Tsai CC; Chen CL; Chen TY; Chen YP; Lin YS; Lu PJ; Lin CM; Wang SH; Tsao CW; Wang CY; Cheng YL; Hsieh CY; Tseng PC; Lin CF
    FASEB J; 2011 Oct; 25(10):3661-73. PubMed ID: 21705667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells.
    di Bartolomeo S; Spinedi A
    Biochem Biophys Res Commun; 2001 Oct; 288(1):269-74. PubMed ID: 11594784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine.
    Sietsma H; Veldman RJ; Kolk D; Ausema B; Nijhof W; Kamps W; Vellenga E; Kok JW
    Clin Cancer Res; 2000 Mar; 6(3):942-8. PubMed ID: 10741719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of [(3)H]thymidine transport is a nonspecific effect of PDMP in primary cultures of mouse epidermal keratinocytes.
    Griner RD; Bollag WB
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1219-24. PubMed ID: 10945880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.
    Bieberich E; Freischütz B; Suzuki M; Yu RK
    J Neurochem; 1999 Mar; 72(3):1040-9. PubMed ID: 10037475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D,L-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (DL-PDMP) increases endoplasmic reticulum stress, autophagy and apoptosis accompanying ceramide accumulation via ceramide synthase 5 protein expression in A549 cells.
    Yamane M; Miyazawa K; Moriya S; Abe A; Yamane S
    Biochimie; 2011 Sep; 93(9):1446-59. PubMed ID: 21571032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol stimulates ganglioside biosynthesis, neurite outgrowth and synapse formation in cultured cortical neurons, and ameliorates memory deficits in ischemic rats.
    Inokuchi J; Kuroda Y; Kosaka S; Fujiwara M
    Acta Biochim Pol; 1998; 45(2):479-92. PubMed ID: 9821877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of glucosylceramide synthase by synthase inhibitors and ceramide.
    Abe A; Radin NS; Shayman JA
    Biochim Biophys Acta; 1996 Feb; 1299(3):333-41. PubMed ID: 8597588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo influence of ceramide accumulation induced by treatment with a glucosylceramide synthase inhibitor on ischemic neuronal cell death.
    Hisaki H; Shimasaki H; Ueta N; Kubota M; Nakane M; Nakagomi T; Tamura A; Masuda H
    Brain Res; 2004 Aug; 1018(1):73-7. PubMed ID: 15262207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.
    Jiang Y; DiVittore NA; Kaiser JM; Shanmugavelandy SS; Fritz JL; Heakal Y; Tagaram HR; Cheng H; Cabot MC; Staveley-O'Carroll KF; Tran MA; Fox TE; Barth BM; Kester M
    Cancer Biol Ther; 2011 Oct; 12(7):574-85. PubMed ID: 21795855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of ganglioside biosynthesis and neurite outgrowth of primary cultured neurons by L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.
    Usuki S; Hamanoue M; Kohsaka S; Inokuchi J
    J Neurochem; 1996 Nov; 67(5):1821-30. PubMed ID: 8863486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
    Shabbits JA; Mayer LD
    Mol Cancer Ther; 2002 Jan; 1(3):205-13. PubMed ID: 12467215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
    Norris-Cervetto E; Callaghan R; Platt FM; Dwek RA; Butters TD
    J Biol Chem; 2004 Sep; 279(39):40412-8. PubMed ID: 15263008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C6 ceramide sensitizes the anti-hepatocellular carcinoma (HCC) activity by AZD-8055, a novel mTORC1/2 dual inhibitor.
    Liu M; Gu P; Guo W; Fan X
    Tumour Biol; 2016 Aug; 37(8):11039-48. PubMed ID: 26897748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing ceramides sensitizes genistein-induced melanoma cell apoptosis and growth inhibition.
    Ji C; Yang YL; He L; Gu B; Xia JP; Sun WL; Su ZL; Chen B; Bi ZG
    Biochem Biophys Res Commun; 2012 May; 421(3):462-7. PubMed ID: 22507982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophic and neuroprotective actions of an enhancer of ganglioside biosynthesis.
    Inokuchi J
    Int Rev Neurobiol; 2009; 85():319-36. PubMed ID: 19607978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of glycosphingolipid biosynthesis by L-threo-1-phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells.
    Inokuchi J; Usuki S; Jimbo M
    J Biochem; 1995 Apr; 117(4):766-73. PubMed ID: 7592537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ceramide metabolism sensitizes human leukemia cells to inhibition of BCL2-like proteins.
    Casson L; Howell L; Mathews LA; Ferrer M; Southall N; Guha R; Keller JM; Thomas C; Siskind LJ; Beverly LJ
    PLoS One; 2013; 8(1):e54525. PubMed ID: 23342165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.